MCRB
Seres Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.96 / 10
Netural
Seres Therapeutics' fundamental score is 6.0/10, reflecting a balanced profile. Key strengths include a healthy interest coverage ratio (15.48) and robust revenue growth (Total operating revenue YoY +78.47%, Operating revenue YoY +92.66%). However, concerns arise from a high Days sales outstanding (1094.23 days) and elevated PB-ROE (22.34), which offset some positives. Net income is positive relative to revenue, and asset/cash metrics are in line with peers, but the mixed factor evaluation results in a neutral fundamental rating.
Analysis Checks(8/10)
Revenue-MV
Value-7.03
Score3/3
Weight15.95%
1M Return10.54%
Value-7.03
Score3/3
Weight15.95%
1M Return10.54%
Days sales outstanding
Value1094.23
Score1/3
Weight-1.75%
1M Return-1.57%
Value1094.23
Score1/3
Weight-1.75%
1M Return-1.57%
Net income-Revenue
Value4.30
Score2/3
Weight12.73%
1M Return8.45%
Value4.30
Score2/3
Weight12.73%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.27%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.27%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight23.57%
1M Return13.15%
Value-0.50
Score3/3
Weight23.57%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.36%
1M Return1.11%
Value78.47
Score2/3
Weight1.36%
1M Return1.11%
Profit-MV
Value-1.21
Score3/3
Weight15.33%
1M Return9.28%
Value-1.21
Score3/3
Weight15.33%
1M Return9.28%
PB-ROE
Value22.34
Score1/3
Weight15.48%
1M Return9.57%
Value22.34
Score1/3
Weight15.48%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.52%
1M Return0.43%
Value92.66
Score2/3
Weight0.52%
1M Return0.43%
Cash-MV
Value-3.71
Score3/3
Weight18.09%
1M Return9.67%
Value-3.71
Score3/3
Weight18.09%
1M Return9.67%
Revenue-MV
Value-7.03
Score3/3
Weight15.95%
1M Return10.54%
Value-7.03
Score3/3
Weight15.95%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.36%
1M Return1.11%
Value78.47
Score2/3
Weight1.36%
1M Return1.11%
Days sales outstanding
Value1094.23
Score1/3
Weight-1.75%
1M Return-1.57%
Value1094.23
Score1/3
Weight-1.75%
1M Return-1.57%
Profit-MV
Value-1.21
Score3/3
Weight15.33%
1M Return9.28%
Value-1.21
Score3/3
Weight15.33%
1M Return9.28%
Net income-Revenue
Value4.30
Score2/3
Weight12.73%
1M Return8.45%
Value4.30
Score2/3
Weight12.73%
1M Return8.45%
PB-ROE
Value22.34
Score1/3
Weight15.48%
1M Return9.57%
Value22.34
Score1/3
Weight15.48%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.27%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.27%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.52%
1M Return0.43%
Value92.66
Score2/3
Weight0.52%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight23.57%
1M Return13.15%
Value-0.50
Score3/3
Weight23.57%
1M Return13.15%
Cash-MV
Value-3.71
Score3/3
Weight18.09%
1M Return9.67%
Value-3.71
Score3/3
Weight18.09%
1M Return9.67%
Is MCRB fundamentally strong?
- MCRB scores 5.96/10 on fundamentals and holds a Fair valuation at present. Backed by its 73.18% ROE, 0.00% net margin, 1.42 P/E ratio, 2.80 P/B ratio, and 107.21% earnings growth, these metrics solidify its Netural investment rating.
